Tasly Pharmaceutical Group
Tasly Pharmaceutical Group is a leading Chinese pharmaceutical company with a strong focus on traditional Chinese medicine (TCM) and modern medicine research and development. Founded in 1994, Tasly has grown to become one of China's largest pharmaceutical companies, with a global presence in over 60 countries, including various Asian markets.
The company's core mission is to integrate the essence of traditional Chinese medicine with modern scientific advancements to develop innovative and effective healthcare solutions. Tasly is known for producing a wide range of products, including herbal-based dietary supplements, herbal extracts, traditional Chinese medicine formulations, and modern pharmaceutical drugs.
Tasly places a significant emphasis on research and innovation, investing heavily in its research and development centers to drive advancements in healthcare. The company collaborates with renowned research institutions and universities to explore the therapeutic potential of traditional Chinese herbs and develop evidence-based products.
One of Tasly's flagship products is Danshen Plus, a herbal supplement derived from Salvia miltiorrhiza, a traditional Chinese herb known for its cardiovascular benefits. The company has also developed other herbal-based supplements targeting various health concerns, including liver health, immune support, and digestive well-being.
In addition to its focus on product development, Tasly is committed to ensuring product quality and safety. The company adheres to strict quality control measures and has obtained numerous certifications to meet international standards, including Good Manufacturing Practice (GMP) certifications for its manufacturing facilities.
Founded: 1994
Headquarters: Tianjin, China
Facebook: https://www.facebook.com/taslyint/
Website: https://en.tasly.com/
